Syed Ali-Aamir Rizvi's Net Worth
$424 Thousand
Who is Syed Ali-Aamir Rizvi?
Syed Ali-Aamir Rizvi does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Caribou Biosciences, Inc..
SEC CIK
Syed Ali-Aamir Rizvi's CIK is 0001897621
Past Insider Trading and Trends
2022 was Syed Ali-Aamir Rizvi's most active year for acquiring shares with 2 total transactions. Syed Ali-Aamir Rizvi's most active month to acquire stocks was the month of December. 2023 was Syed Ali-Aamir Rizvi's most active year for disposing of shares, totalling 1 transactions. Syed Ali-Aamir Rizvi's most active month to dispose stocks was the month of December. 2022 saw Syed Ali-Aamir Rizvi paying a total of $0.00 for 221,250 shares, this is the most they've acquired in one year. In 2023 Syed Ali-Aamir Rizvi cashed out on 5,627 shares for a total of $35,506.37, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Caribou Biosciences, Inc. (CRBU) Snapshot price: $6.545
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -8.66% | -5.63K |
$6.31 | -$35,506.37 | 59.37K |
Jan 19
| |||
Form 4
| +1,200.00% | 60K |
—
|
—
| 65K |
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Poseida Therapeutics, Inc. (PSTX) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 185K |
—
|
—
| 185K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |